The Trump administration is moving ahead with a proposal that would require drug companies to include the sticker prices of their products in direct-to-consumer advertising — a controversial part of President Trump’s blueprint for lower drug prices.
Between the lines: As simple and straightforward as price disclosures might sound, this information may not end up being very useful. Few patients pay the sticker price for a drug. Their insurance plans negotiate discounts, and then often pay only a fraction of that amount.
Maybe they should be forced to offer the same price to everyone, instead of complicated and shady “discounts” to insurance companies. Or at least forced to disclose the lowest price they charge to anyone.
- This Is The Real Reason Why They Raided Mar-a-Lago
- Congressional Republicans, Like Democrats, Want Trump Out Of The Picture Because They Are Both Bought And Paid For By The Same Tribe
- The U.S. Government: The Information Is Classified as Above Top Secret, We Can’t Name the Agencies Involved
- This Is How Globo Homo Works
- China Just Made A Move That Could Literally Provoke A Major War With The United States
- Are We Witnessing The Collapse Of America’s System Of Government?
- Bill Gates Developing Vaccine That Spreads ‘Like a Virus’ To Vaccinate People Without Consent
- The Government Is Hiding a Serious Economic Secret
- China’s Warning ENTIRE Economy Will Collapse In 34 Days
- The Fed-created wild drooling “investors” have learned nothing & huge comeuppance is ahead. The version 2.0 of The Big Short begins…